All Opioid Pain Meds to Get New Safety Warnings, FDA Says Updated labeling to include warning about opioid-induced hyperalgesia Apr 13, 2023
Rexulti Works for Agitation in Alzheimer's, Despite Risks, Says FDA Staff Increased mortality risk consistent with other antipsychotics in elderly dementia patients Apr 13, 2023
The Promise of the $5 Billion Investment in 'Project Next Gen' Here's how to make it money well spent Apr 13, 2023
Reworked Philips CPAP, BiPAP Machines May Not Deliver Correct Therapy And some of the remediated breathing devices may not provide any treatment at all, FDA warns Apr 10, 2023
FDA Approval Authority in Jeopardy? TB Hits the Casino; Sen. Blumenthal's Surgery Health news and commentary from around the Web gathered by 鶹ý staff Apr 10, 2023
NIH's Genome Chief Says Genomics Is Evolving and Docs Need More Education on It National Human Genome Research Institute Director Eric Green sits down with 鶹ý Apr 07, 2023
FDA Yanks Only Preterm Birth Drug, Effective Immediately Months after advisors recommended Makena's approval be withdrawn, FDA announces final decision Apr 06, 2023
CMS Cracks Down on Medicare Advantage Marketing, Prior Auth Practices Agency wants to stop schemes that mislead beneficiaries and prohibit unfair denials of care Apr 06, 2023
New DEA License Requirement Starts in June The X waiver is gone, but clinicians may need new training to renew their DEA license Apr 05, 2023
Monopoly Be Gone: A New Chapter in U.S. Organ Procurement and Transplantation A recent announcement from HHS has the power to transform our deeply flawed system Apr 04, 2023
Mail-Back Envelopes Will Be Dispensed With Outpatient Opioid Scripts Strategy will provide another option to dispose of unneeded medications, FDA says Apr 03, 2023
Experts Call for PBM Transparency During Senate Hearing "Every drug should have a price that is accessible to every American at any time," witness argues Mar 31, 2023
Moderna's Steep COVID Vaccine Price: Corporate Greed or Capitalism? Lessons learned and next steps for public-private vaccines Mar 30, 2023
Do Away With 'Lockout' Period in iPLEDGE, FDA Advisors Urge It's an "unduly high burden" on patients, says one advisory committee member Mar 29, 2023
'No Safe Place': Shooting Hits Home for Nashville Doctors Pediatric surgeon: "Why are our children being massacred in their schools?" Mar 29, 2023
Isotretinoin REMS Still Needed, but Its Burden Could Be Reduced, FDA Staff Says Report suggests ways to lighten documentation rules for prescribing the severe acne treatment Mar 27, 2023
FDA Greenlights First Drug for Rare Immunodeficiency Disease Activated PI3K-delta syndrome may have a new standard of care Mar 27, 2023
FDA Faults Next-Gen Olympus Duodenoscopes After demanding single-use devices, agency finds they have their own problems Mar 27, 2023
FDA: Watch for Joint Replacement Device Failure After Exactech Recall Revision surgery only recommended for patients with pain Mar 23, 2023
A Conservative Blueprint for Universal Healthcare Achieving universal coverage is possible using the ACA as a framework Mar 23, 2023
FDA Panel Supports Tofersen for Rare Genetic ALS In a first, agency advisors back neurofilament light as a surrogate endpoint Mar 23, 2023
Biden Administration Announces Plan to Overhaul the Organ Transplant System Steps include making contracting more competitive and publishing donation data Mar 22, 2023
FDA OKs Another PD-1 Inhibitor for Merkel Cell Carcinoma Retifanlimab produced responses in 52% of patients with untreated unresectable disease Mar 22, 2023
FDA Has Neglected Clinical Trial Transparency — Plus $45 Billion in Fines It's time for more aggressive enforcement of the law Mar 21, 2023
Investigational ALS Drug May Have Clinical Benefit, FDA Staff Says Neurofilament light will be evaluated as a surrogate endpoint in tofersen review Mar 20, 2023
FDA Allows Lower Risk Designation for Snuff Product The brand joins a limited few granted modified risk tobacco claims Mar 16, 2023
More Money, Better Standards Needed to Improve Health Cybersecurity, Senators Told Small rural hospitals especially at risk, witness says Mar 16, 2023
CDC, FDA Heads Fire Back at Ladapo Letter Califf and Walensky say Florida Surgeon General's VAERS analysis is "incorrect, misleading" Mar 13, 2023
A Third of Docs Blame Prior Authorizations for Serious Harm to Patients Four in five say they waste resources, forcing use of ineffective treatments, extra visits Mar 13, 2023
AMA, Surgeon General Propose Ways to Prevent Doctor Burnout Get enough sleep, stop prior authorization, and share your story with colleagues Mar 10, 2023
FDA Panel Endorses New First-Line Lymphoma Regimen POLARIX trial supports a favorable risk-benefit profile for polatuzumab vedotin, ODAC members say Mar 10, 2023
First Bimodal Neuromodulation Device for Tinnitus Gets FDA Nod Ringing ears may get relief with sound and tongue stimulation Mar 08, 2023
Only Drug to Prevent Preterm Birth Set to Leave the Market Decision follows FDA advisory committee recommendation for withdrawal Mar 08, 2023
FDA Not Quite Sold on Polivy in Frontline Large B-Cell Lymphoma Regimen Ahead of ODAC meeting, agency reviewers suggest modest PFS results in POLARIX "raise uncertainty" Mar 07, 2023
FDA Mandate on Acetaminophen-Opioid Combinations Appeared Effective Hospitalizations for liver toxicity declined after FDA limited acetaminophen dose Mar 07, 2023
Stella Immanuel Highest U.S. Prescriber of Ivermectin and HCQ Controversial physician has doled out tens of thousands of scripts for both drugs Mar 02, 2023
Expanding ICD Codes May Aid Rare Disease Patients, Research NCATS explores how best to use diagnostic codes to move field forward Mar 02, 2023
Hopkins' Makary Tells Lawmakers COVID Lab Leak a 'No-Brainer' Other expert witnesses open to other origin theories Mar 01, 2023
First Treatment Approved for Rare Neurodegenerative Disorder Omaveloxolone gets FDA nod for Friedreich's ataxia Mar 01, 2023
Omecamtiv Mecarbil for Heart Failure Turned Down by FDA End of the road for cardiac myosin activator Mar 01, 2023
